Literature DB >> 23329966

Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial.

Mahyar Ghafoori1, Madjid Shakiba, Hamidreza Seifmanesh, Kamal Hoseini.   

Abstract

BACKGROUND: Infection after transrectal ultrasound (TRUS) guided biopsy of the prostate is a major and potentially life-threatening problem. Using antibiotic premedication can not completely eliminate infection after biopsy.
OBJECTIVES: We performed this study to determine the value of using povidone-iodine in prevention of post biopsy infection. PATIENTS AND METHODS: Totally, 280 patients who were referred for TRUS guided biopsy of the prostate were divided randomly into two equal groups. The case group received an intrarectal mixture of povidone-iodine and lidocaine gel before performing biopsy, while the control group received only lidocaine gel. Patients were followed up for 30 days for possible signs of infection including fever, chills and dysuria.
RESULTS: The mean age in the case group was 68.7 ± 7 years and 68.1 ± 7 years in the control group (P = 0.78). Overall, there were signs and symptoms of infection in 78 patients (27.9%), of which 27 (19.3%) were in the case group, while 51 (36.4%) were in the control group (P = 0.001, OR = 2.4, 95% CI = 1.4-4.1).
CONCLUSION: Simple use of widely available povidone-iodine for cleaning the rectum before TRUS guided prostate biopsy can reduce the infection rate.

Entities:  

Keywords:  Biopsy; Infection; Povidone-Iodine; Prostate; Ultrasonography

Year:  2012        PMID: 23329966      PMCID: PMC3522353          DOI: 10.5812/iranjradiol.7561

Source DB:  PubMed          Journal:  Iran J Radiol        ISSN: 1735-1065            Impact factor:   0.212


1. Background

Transrectal ultrasound (TRUS) guided biopsy of the prostate is used widely to detect prostate cancer. This procedure has several minor and major known complications including infection that manifests clinically as fever, chills and dysuria (1). Antibiotic premedication is used routinely to decrease this complication (2, 3, 4), but despite the use of antibiotics, infection develops in many patients with various degrees, from pyuria without clinical symptoms to life-threatening septicemia (5, 6, 7). Different additional methods have been studied for reducing the rate of infection following TRUS guided biopsy including the use of cleansing enema before the procedure (8, 9, 10, 11, 12, 13, 14, 15). However, the results are different. Limited studies are available regarding the use of local antiseptic materials.

2. Objectives

As we met decrease in the rate of post biopsy infection with the local use of povidone-iodine antiseptic mixture in our department and considering the fact that these gels and solutions are cheap, safe and easily available, this study was designed to evaluate the efficacy of local use of povidone-iodine as an antiseptic agent in decreasing the rate of infection following TRUS guided biopsies of the prostate.

3. Patients and Methods

The total number of 280 patients who were referred from the Urology Clinic to the Radiology Department of Hazrat Rasoul Akram University-affiliated Hospital from July 2009 to November 2010 was enrolled into the study. All patients were indicated for systematic TRUS guided biopsy of the prostate as investigation for prostate cancer either due to elevated prostate specific antigen (PSA) or abnormal digital rectal exam. Patients who had symptoms of urinary tract infection, patients with diabetes or known immune deficiency, patients who received steroids, patients with indwelling urinary catheters and patients who consumed antibiotics other than our routine protocol were excluded from the study. Patients were divided randomly into two groups, each containing 140 patients (Figure 1). We used four blocking methods for randomization. All the patients as well as the person who followed up the patients were blind to the randomization. Randomization was designed by the researchers; the enrollment process was performed by a nurse. In each patient, 12 core biopsy specimens were obtained by an automatic tru-cut 18 gauge biopsy needle. Antibiotic premedication (ofloxacin 300 mg every 12 hours and metronidazole 250 mg every eight hours) was prescribed to all patients started the day before biopsy and continued for four days. All patients also received rectal bisacodyl suppository 10 mg the night before and on the morning of the biopsy. Before the biopsy in the povidone iodine prescribed group, a mixture containing 50 gr of lidocaine 2% gel with 20 milliliters of povidone-iodine solution was administered into the rectum via a gavage syringe as a lubricant as well as disinfectant. In the control group, only 50 gr of lidocaine gel was administered into the rectum before the biopsy. The mixture and also lidocaine were prepared by a nurse who was not involved in the study. All the patients were blind to the type of gel introduced into the rectum. Biopsy specimens were obtained five minutes after application of gel mixture or lidocaine. Patients were followed-up for 30 days for possible signs of infection including fever (temperature ≥ 38), chills and dysuria. In patients with severe symptoms, blood culture tests were performed to rule out septicemia.
Figure 1

Patients' enrollment, follow up and analysis

4. Results

The mean age of patients in the povidone-iodine prescribed group was 68.7 ± 7 years and 68.1 ± 7 years in the control group (P = 0.78). No patients were lost from follow up and we were able to follow all the cases. The mean PSA of the patients was 13.1 ± 12.9. Totally, 78 patients (27.9%) showed signs of infection that needed treatment. Of these, we had 27 cases (19.3%) of infection in the case group, while 51 patients (36.4%) developed infection in the control group (P = 0.001, odds ratio (OR) = 2.4, 95% confidence interval = 1.4-4.1). The comparison of infection between the povidone-iodine prescribed group and the control group has been shown in Figure 2. Among the patients who developed symptomatic infection, 11 patients in the case group (7.9% out of total cases) and 27 patients in the control group (19.3% of total controls) needed hospitalization due to severity of their condition (P = 0.005, OR = 2.8, 95% CI = 1.3-5.9). In two patients of the povidone-iodine prescribed group (1.4% of total cases) and six patients of the control group (4.3% of total controls), septicemia happened that was proved by blood culture test (P = 0.28). No mortality due to biopsy complications happened in neither of the groups. We did not meet any complication or local irritation regarding the local use of povidone-iodine or lidocaine gel.
Figure 2

Comparison of infection between the povidone-iodine intervention and control groups

The statistical analysis of the collected data was performed by SPSS version 16. The values of the variables were given as means ± standard deviations. Normality of variables was checked. Comparison between groups was performed by the independent sample t test and chi square test. A P value lower than 0.05 was considered statistically significant.

5. Discussion

Although several complications have been described for TRUS guided biopsy of the prostate (1), the major and most life-threatening of them is infection. It potentially may lead to sepsis (7, 16, 17). Our study shows that enema with a gel mixture containing 50 gram of lidocaine 2% gel with 20 milliliters of povidone-iodide solution as lubricant and disinfectant can significantly reduce the infection rate after biopsy, either prostatitis or more severe life-threatening septicemia, like other studies (9, 10, 11, 14, 18). Although the frequency of septicemia was higher in the control group (three-fold), the difference was not statistically significant. It may be due to the low prevalence of septicemia in the two groups regarding the total sample size. In a similar study, Park et al.(14) studied the effect of povidone-iodine suppository on infectious complication after TRUS guided biopsy of the prostate. Totally, infectious complications occurred in 6.6% of the rectally non prepared group while in the rectally prepared group, only one patient was involved (0.3%). Although they found a lower rate of infection in each of the study groups compared with our study, their results are in agreement with our study regarding this fact that the control group faced more infections than the povidone-iodine prescribed group. Acute prostatitis is a major infectious complication of TRUS guided biopsy of the prostate and E.coli has been reported to be the main cause (19). Park et al. (14) suggested that melting povidone-iodine into the rectum may decrease the bacterial colony count (including E.coli). Another study by Kanjanawongdeengam et al. (11) on 100 patients has reported similar results to our study. They found that sterilization of the rectum before TRUS guided prostate biopsy can reduce clinical infections. Huang et al. (9) also reported that bowel preparation before prostate biopsy using povidone-iodine (in addition to antibiotic prophylaxis) is an effective way to reduce the infection. There are two older studies that are in agreement with our study (10, 13). A reverse result was reported by Koc et al. (12). They enrolled 180 patients and used a needle that was washed with povidone-iodine for the povidone-iodine prescribed group. Considering infection, there was no statistically significant difference between the two groups. They concluded that washing the biopsy needle with povidone-iodine cannot reduce the infection rate. It may be due to insufficient sterilization of the washed needle. They only used a washed needle with povidone-iodine while we introduced povidone-iodine into the rectum. A very recent study (15) has reported that prebiopsy enema does not have a significant effect on reducing the overall complication rate. However, they found that the incidence of infection or sepsis in the prebiopsy enema group was lower than the rectally non-prepared group (P > 0.05). Using antibiotic premedication is still the best way for prevention of infectious complications of TRUS guided biopsy of the prostate. However, use of povidone-iodine solution is found to be a simple and cheap way to further reduce infectious complications. A considerable percent of patients develop infection following TRUS guided prostate biopsy despite oral antibiotic premedication. The difference in the rate of infection between the two groups was significant and adding povidone-iodine to lidocaine gel may decrease the rate of infection.
  19 in total

Review 1.  Disseminated intravascular coagulation following transrectal ultrasound guided prostate biopsy.

Authors:  M F Al-Otaibi; W Al-Taweel; S Bin-Saleh; M Herba; A G Aprikian
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

2.  Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate.

Authors:  M D Melekos
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 3.  [Antibiotic prophylaxis in transrectal prostate biopsy].

Authors:  Daniel Muñoz Vélez; Antoni Vicens Vicens; Mariano Ozonas Moragues
Journal:  Actas Urol Esp       Date:  2009-09       Impact factor: 0.994

4.  Modified bowel preparation to reduce infection after prostate biopsy.

Authors:  Yun-Ching Huang; Dong-Ru Ho; Ching-Fang Wu; Jia-Jen Shee; Wei-Yu Lin; Chih-Shou Chen
Journal:  Chang Gung Med J       Date:  2006 Jul-Aug

5.  Is it possible to predict sepsis, the most serious complication in prostate biopsy?

Authors:  Adnan Simsir; Erkan Kismali; Rashad Mammadov; Gurhan Gunaydin; Cag Cal
Journal:  Urol Int       Date:  2010-03-12       Impact factor: 2.089

6.  [A case of septic shock and disseminated intravascular coagulation following transrectal prostatic biopsy].

Authors:  K Kato; K Suzuki; S Sai; M Senda; T Murase
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  2001-11

7.  Meta-analysis of antibiotic prophylaxis use in transrectal prostatic biopsy.

Authors:  Minggen Yang; Xiaokun Zhao; Zhiping Wu; Ning Xiao; Chen Lu
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2009-02

8.  Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy.

Authors:  Henry S S Ho; Lay Guat Ng; Yeh Hong Tan; Mavis Yeo; Christopher W S Cheng
Journal:  Ann Acad Med Singapore       Date:  2009-03       Impact factor: 2.473

9.  Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: a randomized controlled trial.

Authors:  Panupong Kanjanawongdeengam; Wit Viseshsindh; Pitak Santanirand; Prapapan Prathombutr; Supannee Nilkulwattana
Journal:  J Med Assoc Thai       Date:  2009-12

10.  Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy.

Authors:  Dong Soo Park; Jong Jin Oh; Jin Ha Lee; Woong Ki Jang; Young Kwon Hong; Sung Keun Hong
Journal:  Adv Urol       Date:  2009-04-23
View more
  19 in total

1.  Intra-abdominal bacterial contamination in TAMIS total mesorectal excision for rectal carcinoma: a prospective study.

Authors:  Simone Velthuis; Marloes Veltcamp Helbach; Jurriaan B Tuynman; Thuy-Nga Le; H Jaap Bonjer; Colin Sietses
Journal:  Surg Endosc       Date:  2015-02-11       Impact factor: 4.584

Review 2.  Prevention and treatment of biopsy-related complications.

Authors:  Ramgopal Satyanarayana; Dipen Parekh
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

3.  Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.

Authors:  Ji Won Ryu; Seung Il Jung; Ji Hoon Ahn; Eu Chang Hwang; Ho Song Yu; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Jin Woong Kim
Journal:  Int Urol Nephrol       Date:  2016-08-05       Impact factor: 2.370

Review 4.  Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: a systematic review and meta-analysis.

Authors:  Chunxiao Pu; Yunjin Bai; Haichao Yuan; Jinhong Li; Yin Tang; Jia Wang; Qiang Wei; Ping Han
Journal:  Int Urol Nephrol       Date:  2014-04-18       Impact factor: 2.370

5.  Critical concepts and important anatomic landmarks encountered during transanal total mesorectal excision (taTME): toward the mastery of a new operation for rectal cancer surgery.

Authors:  S Atallah; M Albert; J R T Monson
Journal:  Tech Coloproctol       Date:  2016-05-17       Impact factor: 3.781

Review 6.  Anatomical Considerations and Procedure-Specific Aspects Important in Preventing Operative Morbidity during Transanal Total Mesorectal Excision.

Authors:  Sam Atallah
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

7.  Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.

Authors:  Eu Chang Hwang; Seung Il Jung; Young Ho Seo; Se Heon Jeong; Dong Deuk Kwon; Kwangsung Park; Jin Woong Kim
Journal:  Int Urol Nephrol       Date:  2015-02-25       Impact factor: 2.370

8.  Topical rectal antiseptic at time of prostate biopsy: how a resident patient safety project has evolved into institutional practice.

Authors:  Rosa Park; Justin Gyorfi; Kalyan Dewan; Girish Kirimanjeswara; Joseph Y Clark; Matthew G Kaag; Kathleen Lehman; Jay D Raman
Journal:  Int Urol Nephrol       Date:  2018-07-17       Impact factor: 2.370

9.  The value of prostate MRI with endorectal coil in detecting seminal vesicle involvement in patients with prostate cancer.

Authors:  Mahyar Ghafoori; Manijeh Alavi; Madjid Shakiba; Kamal Hoseini
Journal:  Iran J Radiol       Date:  2015-01-17       Impact factor: 0.212

10.  Prostate Biopsy Using Transrectal Ultrasonography; The Optimal Number of Cores Regarding Cancer Detection Rate and Complications.

Authors:  Mahyar Ghafoori; Meysam Velayati; Mounes Aliyari Ghasabeh; Madjid Shakiba; Manijeh Alavi
Journal:  Iran J Radiol       Date:  2015-04-22       Impact factor: 0.212

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.